BC
FMTX

Brookfield Corp’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Brookfield Corp’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-150,100
Closed -$2.99M – 802
2022
Q3 		$2.99M Buy
+150,100
New +$1.98M 0.01% 371

Brookfield Corp's FMTX Position: Q4 2022 in Review

Brookfield Corp sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 150,100 shares — an estimated $2.99M sold.

Brookfield Corp first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $2.99M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Brookfield Corp reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Brookfield Corp sold 150,100 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $2.99M.
  • Brookfield Corp first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Brookfield Corp's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $2.99M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Brookfield Corp's 13F filing for Q4 2022, filed 14 Feb 2023.